Mirae Asset Global Etfs Holdings »

Bridgebio Oncology Therapeut shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $20k 2.6k 7.66

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Apple (AAPL)
Cameco Corporation (CCJ)
Global X Fds Russell 2000 Etf (RSSL)
Advanced Micro Devices (AMD)
Intel Corporation (INTC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Wheaton Precious Metals Corp (WPM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Palantir Technologies Cl A (PLTR)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
EcoR1 Capital
Alphabet
Wellington Management Company
Enavate Sciences GP
Citadel Advisors
Novo A/S
BlackRock
Vanguard Capital Management
Laurion Capital Management
Armistice Capital
Aisling Capital Management
Opaleye Management

View all funds holding Bridgebio Oncology Therapeut